Esophagus, Stomach & Upper GI · Article 110

How Should Gastric Subepithelial Lesions Be Evaluated?

Gastric subepithelial lesions requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Gastric subepithelial lesions clinical reference — Related free clinical resource: Endoscopy and Diagnostic Imaging.

Gastric subepithelial lesions: practical clinical approach

This page focuses on Gastric subepithelial lesions with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Gastric subepithelial lesions

Clinical takeaway: For Gastric subepithelial lesions, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer first: A gastric subepithelial lesion (SEL) should be characterized by size, location, symptoms, mucosal features and wall layer of origin. EUS is the preferred test when the diagnosis is indeterminate or routine biopsies are nondiagnostic. Lesions with classic features of lipoma or pancreatic rest often need no further evaluation. Muscularis propria lesions generally require distinction between GIST and leiomyoma using EUS-guided tissue acquisition, preferably core biopsy when feasible. Management then depends on size, histology, malignant potential and symptoms.

First determine whether it is truly subepithelial

Extrinsic compression, varices and epithelial tumors can mimic an intramural subepithelial mass. Standard endoscopy can reveal clues such as a pillow sign for lipoma, central umbilication of pancreatic rest, ulceration or firmness. Cross-sectional imaging may clarify external compression.

EUS answers the central anatomic questions

EUS identifies the wall layer of origin, echogenicity, margins, cystic spaces, vascularity and relationship to adjacent structures. A hypoechoic muscularis propria lesion raises concern for GIST or leiomyoma; a hyperechoic submucosal lesion is more consistent with lipoma.

Tissue strategy

Simple forceps biopsies often miss deeper lesions. Bite-on-bite/tunnel biopsy may diagnose some submucosal lesions. EUS-guided fine-needle biopsy is particularly useful for muscularis propria lesions when immunohistochemistry is required to distinguish GIST, leiomyoma and other mesenchymal tumors.

Risk, not just size, determines management

Ulceration, bleeding, symptoms, irregular margins and growth increase concern. Gastric GISTs larger than about 2 cm are generally considered for resection; smaller muscularis propria lesions may be surveilled or sampled depending on features and patient factors.

Practical clinical algorithm

Describe size, location, mobility, mucosal appearance and symptoms.
Exclude obvious lipoma, pancreatic rest, varix or extrinsic compression when possible.
Use EUS for indeterminate lesions or nondiagnostic superficial biopsies.
Obtain tissue when histology will change management, especially muscularis propria lesions.
Refer symptomatic, ulcerated, bleeding, growing or higher-risk lesions for resection evaluation.
Surveil selected small low-risk lesions using EUS/endoscopy according to histology and local guidance.

Common mistakes to avoid

Taking repeated superficial biopsies from a deep lesion.
Calling every muscularis propria lesion a GIST without tissue.
Resecting a classic asymptomatic lipoma.
Ignoring ulceration or interval growth.
Attempting advanced resection without appropriate expertise.

Trainee takeaway

The practical sequence is characterize, layer, sample if necessary, then risk-stratify. EUS is central because management depends on where the lesion comes from and what it is likely to be.

Frequently asked questions

Does every subepithelial lesion need EUS?

No. Classic benign lesions such as lipoma or pancreatic rest may not require further evaluation when the diagnosis is secure.

Should every small muscularis propria lesion be resected?

No. Selected lesions under 2 cm can be surveilled, particularly when asymptomatic and lacking high-risk features.

FNA or FNB?

Core FNB is often preferred when immunohistochemistry and architecture are important, such as suspected GIST.

References

1. Thomson ABR. Endoscopy and Diagnostic Imaging. Part I. CAPstone Academic Publishers; 2012.

2. Thomson ABR. Images in Gastroenterology and Hepatology. Part 1. CAPstone Academic Publishers; 2021.

3. Sharzehi K, Sethi A, Savides T. AGA Clinical Practice Update on Management of Subepithelial Lesions Encountered During Routine Endoscopy. Clin Gastroenterol Hepatol. 2022.

4. D’Souza LS, et al. AGA Clinical Practice Update on Endoscopic Full-Thickness Resection for the Management of Gastrointestinal Subepithelial Lesions. Gastroenterology. 2024.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.

← Back to Clinical Questions